JBNB  Vol.5 No.3 , July 2014
Nanotechnological Contribution to Drug Delivery System: A Reappraisal

With the emergence of Nanotechnology, there has been remarkable improvement in the field of drug delivery system over the past decade. Nanotechnology in drug delivery system is an upcoming field and significant research has been conducted in this regard. It has been able to overcome some limitations encountered with the traditional routine drug delivery systems and hence emerged as an effective alternative. This article reviews nanotechnology based different types of drug delivery systems and their therapeutic applications.

Cite this paper: Prasad, P. and Shrivastav, T. (2014) Nanotechnological Contribution to Drug Delivery System: A Reappraisal. Journal of Biomaterials and Nanobiotechnology, 5, 194-199. doi: 10.4236/jbnb.2014.53023.

[1]   The Royal Society and the Royal Academy of Engineering (2014) Nanoscience and Nanotechnologies. The Royal Society and the Royal Academy of Engineering Report.

[2]   Stylios, G.K., Giannoudis, P.V. and Wan, T. (2005) Applications of Nanotechnologies in Medical Practice. Injury, 36, S6-S13.

[3]   Nelson, A.O., Patrick, O.O. and Ndidi, C.N. (2009) Nanotechnology and Drug Delivery. Part 1: Background and Applications. Tropical Journal of Pharmaceutical Research, 8, 265-274.

[4]   Taniguchi, N. (1974) Proc Int Conf Prod Eng, Part II, Japan Society of Precision Engineering, Tokyo.

[5]   Nanotechnology, K.P. (2007) What It Can Do for Drug Delivery. Journal of Controlled Release, 120, 1-3.

[6]   The Nanotechnology Opportunity Report 2008. 3rd Edition.

[7]   Panyam, J. and Labhasetwar, V. (2003) Biogradebale Nanoparticle for Drug and Gene Delivery to Cells and Tissue. Advanced Drug Delivery Reviews, 55, 329-347.

[8]   Italia, J.L., Bhatt, D.K., Bhardwaj, V., Tikoo, K. and Ravi, K. (2007) PLGA Nanoparticle for Oral Delivery of Cyclosporine: Nephrotoxicity and Pharmacokinetic Studies in Comparison to Sandimmune Neural. Journal of Controlled Release, 119, 197-206.

[9]   Sahoo, S.K. and Labhasetwar, V. (2003) Nanotech Approaches to Drug Delivery and Imaging. Drug Discovery Today, 8, 1112-1120.

[10]   Peppas, N.A. (2004) Intellegent Therapeutics: Biomimetic Systems and Nanotechnology in Drug Delivery. Advanced Drug Delivery Reviews, 56, 1529-1531.

[11]   University of Waterloo (2010) Nanotechnology in Targeted Cancer Therapy.

[12]   Lavan, D.A., McGuire, T. and Langer, R. (2003) Small Scale Systems for in Vivo Drug Delivery. Nature Biotechnology, 21, 1184-1191.

[13]   Cavalcanti, A., Shirinzadeh, B., Freitas Jr., R.A. and Hogg, T. (2008) Nanorobot Architecture for Medical Target Identification. Nanotechnology, 19, Article ID: 015103.

[14]   Gonsalves, K.E., et al. (2008) Biomedical Nanostructures. John Wiley & Sons, Inc., Hoboken, New York, USA.

[15]   Brigger, I., Dubernet, C. and Couvreur, P. (2002) Nanoparticles in Cancer Therapy and Diagnosis. Advanced Drug Delivery Reviews, 54, 631-651.

[16]   Prasad, P.V., Kumar, A., Pal, P.C., Sharma, R.S., Rao, D.N., Shrivastav, T.G. and Ge, R.-S. (2011) Bird’s Eye View on the Recent Advances in Drug Delivery Systems. Journal of Biomaterials and Nanobiotechnology, 2, 544-556.

[17]   Santos-Magalhaes, N.S., Pontes, A., Pereira, V.M.W. and Caetano, M.N.P. (2000) Colloidal Carriers for Benzathin Penicillin G: Nanoemulsion and Nanocapsules. International Journal of Pharmaceutics, 208, 71-80.

[18]   Brusewitz, C., Schendler, A., Funke, A., Wagner, T. and Lipp, R. (2007) Novel Poloxamer-Based Nanoemulsions to Enhance the Intestinal Absorption of Active Compunds. International Journal of Pharmaceutics, 329, 1173-1181.

[19]   Chiesa, M., Garg, J., Kang, Y.T. and Cheng, G. (2008) Thermal Conductivity and Viscosity of Water-in-Oil Nanoemulsions. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 326, 67-72.

[20]   Anju, S., Senthil, K. and Mahadevan, N. (2012) Nanotechnology: A Promising Approach for Cosmetics. International Journal of Advances in Pharmaceutical Research, 2, 54-61.

[21]   Soppimath, K.S., Aminbhavi, T.M., Kulkarni, A.R. and Rudzinski, W.E. (2001) Biogradedable Polymeric Nanoparticles as Drug Delivery Devices. Journal of Recent Controlled Release, 70, 1-20.

[22]   Qiu, Y., Gao, Y., Hu, K. and Li, F. (2008) En-hancement of Skin Permeation of Docetaxel: A Novel Approach Combining Micro Needle and Elastic Liposomes. Journal of Controlled Release, 129, 144-150.

[23]   Jia, Y., Joly, H. and Omri, H. (2008) Liposomes as a Carrier for Gentamicin Delivery: Development and Evaluation of the Physio-chemical Properties. International Journal of Pharmaceutics, 359, 254-263.

[24]   Zaru, M., Mourtas, S., Klepetsanis, P., Fadda, A.M. and Antimisiaris, S.G. (2007) Liposomes for Drug Delivery to the Lungs by Nebulization. European Journal of Pharmaceutics and Biopharmaceutics, 76, 655-666.

[25]   Kulkarni, P.R., Yadav, J.D., Vaidya, K.A. and Gandhi, P.P. (2011) Transferosomes: An Emerging Tool for Transdermal Drug Delivery. IJPSR, 2, 735-741.

[26]   Pandey, S., Goyani, M., Devmurari, V. and Fakir, J. (2009) Transferosomes: A Novel Approach for Transdermal Drug Delivery. Der Pharmacia Lettre, 1, 143-150.

[27]   Svenson, S. and Tomalia, D.A. (2005) Dendrimers in Biomedical Applications-Reflections on the Field. Advanced Drug Delivery Review, 57, 2106-2129.

[28]   Nelson, A.O., Patrick, O.O. and Ndidi, C.N. (2009) Nanotechnology and Drug Delivery. Part 2: Nanostructures for Drug Delivery. Tropical Journal of Pharmaceutical Research, 8, 275-287.

[29]   Boas, U. and Heegaard, P.M.H. (2004) Dendrimers in Drug Research. Chemical Society Reviews, 33, 43-63.

[30]   Fischer, D., Li, Y.X., Ahlemeyer, J., Krieglstein, J. and Kissel, T. (2004) In Vitro Cytotoxicity Testing of Polycations: Influence of Polymer Structure on Cell Viability and Hemolysis. Biomaterials, 24, 1121-1131.

[31]   Malik, N., Wiwattananpatapee, R., Klopsche, R., Lorenz, K., Frey, H., Weener, J.W., Meijer, E.W., Paulus, W. and Duncan, R. (2000) Dendimers: Relationship between Structure and Biocompatibility in Vitro, and Preliminary Studies on the Biodistribution of 125I-Labelled Polyamidoamine Dendrimers in Vivo. Journal of Controlled Release, 65, 133-148.

[32]   Yih, T.C. and Al-Fandi, M. (2006) Engineered Nanoparticles as Precise Drug Delivery Systems. Journal of Cellular Biochemistry, 97, 1184-1190.

[33]   Jain, T.K., Roy, I., De, T.K. and Maitra, A. (1998) Nanometer Silica Particles Encapsulating Active Compunds: A Novel Ceramic Drug Carrier. Journal of the American Chemical Society, 120, 11092-11095.

[34]   Medina, C., Santos, M.J., Radomski, A., Corrigan, O. and Radomski, M.W. (2007) Nanoparticles: Pharmacological and Toxicological Significance. British Journal of Pharmacology, 150, 552-558.

[35]   Wissing, S.A., Kayser, O. and Muller, R.H. (2004) Solid Lipid Nanoparticles for Parenteral Drug Delivery. Advanced Drug Delivery Reviews, 56, 1257-1272.

[36]   Godin, B. and Touitou, E. (2003) Ethosomes: New Prospects in Transdermal Delivery. Critical Reviews in Therapeutic Drug Carrier Systems, 20, 63-102.

[37]   Jain, S., Umamaheshwari, R.B., Bhadra, D. and Jain, N.K. (2004) Ethosomes: A Novel Vesicular Carrier for Enhanced Transdermal Delivery of an Anti-HIV Agent. Indian Journal of Pharmaceutical Sciences, 66, 72-81.

[38]   Mnyusiwalla, A., Daar, A.S. and Singer, P.A. (2003) Mind the Gap: Science and Ethics in Nanotechnology. Nanotechnology, 14, R9-R13.

[39]   Basi, C. (2013) Toxic Nanoparticles Might Be Entering Human Food Supply. MU Study Finds, University of Missouri, Columbia.

[40]   Jackie, Y. (2001) Nanostructured Materials. Academic Press, New York.

[41]   Nanotechnologies: 6. What Are Potential Harmful Effects of Nanoparticles? (